10-Q: OneMedNet Corporation Reports First Quarter 2024 Results, Revenue Up 24% Year-Over-Year

OneMedNet Corporation's first quarter 2024 results show a 24% increase in revenue compared to the same period last year, driven by growth in both subscription and web imaging services.

Summary

• OneMedNet Corporation reported a net loss of $2.1 million for the three months ended March 31, 2024, compared to a net loss of $7.8 million for the same period in 2023.
• Total revenue for the quarter was $248 thousand, a 24% increase from $200 thousand in the first quarter of 2023.
• Subscription revenue increased by 20% to $201 thousand, while web imaging revenue rose by 42% to $47 thousand.
• The company's cost of revenue was $317 thousand, resulting in a gross margin of -$69 thousand.
• Operating expenses totaled $2.032 million, including $1.358 million in general and administrative costs, $229 thousand in sales and marketing, and $445 thousand in research and development.
• The company's cash balance was $174 thousand as of March 31, 2024, which is deemed insufficient to fund operations for the next twelve months.
• The company is planning to raise additional working capital through equity or debt offerings.
• The company has identified material weaknesses in its internal controls over financial reporting.

Sentiment

Score: 4

Explanation: The document shows some positive revenue growth, but the significant net loss, going concern issues, material weaknesses in internal controls, and need for further capital raises create a negative sentiment overall. The company is facing significant financial challenges.

Positives

• The company experienced a significant increase in revenue, with a 24% year-over-year growth.
• The net loss improved substantially, decreasing from $7.8 million to $2.1 million year-over-year.
• Cost of revenue as a percentage of revenue decreased by 17% year-over-year.
• The company secured a $1 million line of credit to support short-term working capital needs.

Negatives

• The company reported a net loss of $2.1 million for the quarter.
• The company's cash balance of $174 thousand is not adequate to fund operations for the next twelve months.
• The company has an accumulated deficit of $93.5 million as of March 31, 2024.
• The company has identified material weaknesses in its internal controls over financial reporting.
• General and administrative expenses increased by 152% year-over-year.

Risks

• The company's ability to continue as a going concern is dependent on securing additional financing.
• The company may not be able to secure financing in a timely manner or on favorable terms.
• The company's existing stockholders may experience dilution if equity securities are issued to raise additional funds.
• The company is subject to risks common to companies in the markets it serves, including global economic conditions and competition.
• The company has identified material weaknesses in its internal controls over financial reporting.

Future Outlook

The company plans to raise additional working capital through equity or debt offerings and ultimately hopes to attain profitable operations to fulfill its operating and capital requirements for at least 12 months from the date of the issuance of the condensed consolidated financial statements.

Management Comments

• Management plans to raise additional working capital through an equity or debt offering.
• Management hopes to attain profitable operations to fulfill its operating and capital requirements.

Industry Context

The company operates in the healthcare software industry, specifically focusing on digital medical image management, exchange, and sharing. The growth in revenue suggests a positive trend in the adoption of their solutions within this market. However, the company's financial challenges highlight the competitive nature of the industry and the need for continued innovation and strategic financial management.

Comparison to Industry Standards

• The company's revenue growth of 24% is a positive sign, but it is difficult to compare directly to industry standards without more specific data on comparable companies in the medical imaging software sector.
• Many software companies in the healthcare space are experiencing rapid growth, but profitability remains a challenge for many early-stage companies.
• The company's negative gross margin indicates that its cost of revenue is higher than its revenue, which is not sustainable in the long term and needs to be addressed.
• The company's cash position is weak compared to industry standards, where companies typically maintain a cash runway of at least 12 months.
• The company's reliance on related party loans and the need for additional capital raises are common for early-stage companies but also indicate a higher risk profile.

Management Changes

Corporate Governance

Related Party Transactions

• The company received gross proceeds of $1.0 million in connection with a shareholder loan with a related party investor.
• The company received gross proceeds of $0.3 million in connection with non-convertible shareholder loans with related party investors.
• The company assumed Data Knights liabilities, which included existing loan extensions to related parties.
• The company issued PIPE Notes and Warrants to related party investors.
• The company issued Convertible Promissory Notes and Warrants to related party investors.

Stakeholder Impact

• Shareholders may experience dilution if the company issues equity securities to raise additional funds.
• Employees may be affected by the company's financial instability and potential restructuring.
• Customers may be concerned about the company's ability to continue providing services.
• Suppliers and creditors may face increased risk due to the company's financial challenges.

Next Steps

• The company intends to raise cash for operations through debt and equity offerings.
• The company plans to enhance its internal control structure, including appropriate segregation of duties.
• The company will continue discussions with Yorkville regarding the breach of the registration rights agreement.

Key Dates

Keywords

medical imaging, healthcare software, revenue growth, financial results, net loss, going concern, capital raise, internal controls, subscription revenue, web imaging